|
MechanismKCNQ (Kv7) modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with 1st Order Pharmaceuticals, Inc.
0 Patents (Medical) associated with 1st Order Pharmaceuticals, Inc.
100 Deals associated with 1st Order Pharmaceuticals, Inc.
100 Translational Medicine associated with 1st Order Pharmaceuticals, Inc.